| Document |
Document Title |
|
WO/2021/066435A1 |
The present invention relates to a compound for an organic electric element, an organic electric element using same, and an electronic device comprising the organic electric element. According to the present invention, an organic electri...
|
|
WO/2021/060276A1 |
Provided, inter alia, is a fluorinating agent that can selectively produce a monofluorination product through preferential synthesis of the monofluorination product over a difluorination product, in a fluorination reaction in which a flu...
|
|
WO/2021/047525A1 |
The present invention relates to the technical field of medicine, and provides a salt of a benzothiopyrone compound, and a preparation method therefor and an application thereof, in particular, a salt of 2-(4-(cyclohexylmethyl)piperazin-...
|
|
WO/2021/049470A1 |
The purpose of the present invention is to provide a compound having excellent acid generation sensitivity. The present invention is a compound represented by general formula (A) below. (In the formula, R11 and R20 each independently r...
|
|
WO/2021/039654A1 |
The present invention provides: an active-ray-sensitive or radiation-sensitive resin composition having a solid material concentration of 10% by mass or more, the active-ray-sensitive or radiation-sensitive resin composition comprising a...
|
|
WO/2021/029158A1 |
The purpose of the present invention is to provide: a sulfonamide compound which has a high decomposition rate in response to near-ultraviolet rays and which generates a superacid bis-sulfonamide, and which is highly soluble in a resist ...
|
|
WO/2021/023119A1 |
Provided is a co-crystal formed by flupentixol dihydrochloride and melitracen hydrochloride, wherein the molar ratio of flupentixol dihydrochloride and melitracen hydrochloride in the co-crystal is 1:1. The co-crystal has a good stabilit...
|
|
WO/2021/026179A1 |
The present invention is directed to compounds of the formula (I) wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositio...
|
|
WO/2021/020429A1 |
The present invention provides a compound represented by formula (I) or a pharmaceutically acceptable salt thereof which has the effect of antagonizing the LPA1 receptor.
|
|
WO/2020/261021A1 |
Described are polymerizable fused tricyclic compounds of formula I: wherein R1, R2, R3, m, n, t, and rings B, C, and D are as defined herein. The compounds absorb various wavelengths of ultraviolet and/or visible light (such as high ener...
|
|
WO/2020/218680A1 |
The present invention relates to a novel organic light emitting compound and an organic electroluminescent diode using same and, more specifically, to: a compound having excellent thermal stability, electrochemical stability, light emitt...
|
|
WO/2020/216777A1 |
The present invention relates to a composition comprising a compound of formula (I) wherein X is selected from the group consisting of S, Se, P, PO, SO, NR1, CR1, CR1R1 or C0-2-alkyl; Z is selected from the group consisting of hydrogen, ...
|
|
WO/2020/159019A1 |
The present invention relates to a novel organic light-emitting compound and an organic electroluminescent device using same and, more specifically, to a compound having excellent thermal stability, electrochemical stability, light-emitt...
|
|
WO/2020/158870A1 |
The purpose in one embodiment of the present invention is to provide a therapeutic for Parkinson's disease, etc. A compound represented by formulas (1), (2), or (8) or a pharmacologically acceptable salt thereof can be used in the treatm...
|
|
WO/2020/151623A1 |
The present invention pertains to the medical field and relates to a compound of formula (III), a stereoisomer or pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the compound, a ster...
|
|
WO/2020/151621A1 |
The present invention belongs to the field of medicine, and specifically relates to a compound of formula (I), an isomer or a pharmaceutical salt thereof. This present invention more specifically relates to a compound, a stereoisomer the...
|
|
WO/2020/153669A1 |
The present invention relates to a compound for an organic electric device, an organic electric device using same, and an electronic apparatus thereof. According to the present invention, high luminous efficiency, low driving voltage, an...
|
|
WO/2020/145043A1 |
Provided are: a novel sulfonium salt which exhibits high photosensitivity to g rays or h rays; and a novel photoacid generator containing a sulfonium salt which exhibits high photosensitivity to g rays or h rays, high solubility in a sol...
|
|
WO/2020/137921A1 |
The present invention provides an actinic light sensitive or radiation sensitive resin composition, a resist film, a pattern forming method, and an electronic device production method, wherein the actinic light sensitive or radiation sen...
|
|
WO/2020/134138A1 |
The present disclosure relates to the technical field of luminescent materials, and relates in particular to an organic electroluminescent compound, a preparation method therefor and an organic electroluminescent device. In order to solv...
|
|
WO/2020/109132A1 |
A radiation curable inkjet ink comprising a polymerizable compound and a photoinitiator, characterized in that the photoinitiator comprises a functional group selected from the group consisting of an aliphatic thio-ether and an aliphatic...
|
|
WO/2020/086691A1 |
This current disclosure is directed to charge-transfer heptamethine dyes for NIR singlet oxygen generation, each such dye comprising a near-infrared (NIR) absorbing dye having heptamethine linkages orthogonally coupled to an optionally s...
|
|
WO/2020/067118A1 |
A dialkyl peroxide including a thioxanthone group, characterized by being represented by general formula (1) (wherein R1, R2, R3, and R4 each independently represent a methyl or ethyl group; R5 represents a C1-6 alkyl group or a phenyl g...
|
|
WO/2020/052774A1 |
The application provides flavone derivatives having the general formula (I) which are useful for the treatment of Hepatitis B Virus infection (HBV). The compounds act as cccDNA (covalently closed circular DNA) inhibitors.
|
|
WO/2020/053249A1 |
The present invention provides flavone derivatives having the general formula (I) which are useful for the treatment of Hepatitis B Virus infection (HBV). The compounds act as cccDNA (covalently closed circular DMA) inhibitors.
|
|
WO/2020/016389A1 |
Latent photoinitiator compounds are described, as well as compositions containing such compounds and their uses in photoinitated methods for producing photoresist structures.
|
|
WO/2020/004601A1 |
Provided are: an oxime ester compound useful as a photopolymerization initiator used in a polymerizable composition; and a photopolymerization initiator containing the oxime ester compound. This compound has a group represented by genera...
|
|
WO/2019/226490A1 |
Provided is a compound of Formula (I), wherein the variable groups are defined herein.
|
|
WO/2019/203491A1 |
The present specification provides a compound of formula 1 and an organic light emitting device comprising same.
|
|
WO/2019/194136A1 |
Provided are a photosensitive composition having an excellent sensitivity, a cured film, a method for manufacturing a color filter, a color filter, a solid-state imaging element, and an image display device. The photosensitive compositio...
|
|
WO/2019/182411A1 |
The present specification relates to a heterocyclic compound of chemical formula 1 and an organic light-emitting device comprising same.
|
|
WO/2019/182360A1 |
Provided, according to the present invention, are a compound which may be applied to an electron transport layer of an organic light-emitting device, an organic light-emitting device using such compound and an organic EL display device c...
|
|
WO/2019/172699A1 |
The present specification provides a compound represented by chemical formula 1 and an organic light emitting device comprising same.
|
|
WO/2019/160079A1 |
Provided are a radical polymerization initiator having excellent sensitivity and solubility in water, a composition containing the same, a cured product of the composition, a production method for the cured product, and a compound. The...
|
|
WO/2019/142880A1 |
A compound represented by formula (I) or a salt thereof. (In formula (I): Q1 represents an optionally substituted C6-10 aryl group; Q2 represents an optionally substituted C6-10 aryl group or an optionally substituted 5-10 membered heter...
|
|
WO/2019/119141A1 |
The present application is directed to compounds of Formula (I): compounds of Formula (II): compounds of Formula (III): and compounds of Formula (IV): compositions comprising these compounds and their uses, for example as medicaments and...
|
|
WO/2019/120099A1 |
The present invention relates to an organic mixture and the use thereof in an organic electronic device. The organic mixture comprises organic materials H1 and H2, wherein H1 is a compound as shown in the following general formula (1), a...
|
|
WO/2019/094788A1 |
The present technology relates to compounds that inhibit human Ly6K and homologs thereof. Also disclosed are methods of using such compounds to: inhibit activity of a Ly6K protein in a cell; decrease migration, colony formation, and/or p...
|
|
WO/2019/085758A1 |
Disclosed in the present invention are a ketone-containing compound and applications thereof in organic electroluminescent devices. The compound consists of ketone and spiroanthracenefluorene groups, has a very deep HOMO energy level and...
|
|
WO/2019/063955A1 |
The present invention concerns the compounds of the following formula (I): (I) in which: - X represents an oxygen atom, a sulfur atom, a nitrogen atom or a CH radical, - The X--Y bond and Y are absent if X represents an oxygen or sulfur ...
|
|
WO/2019/061299A1 |
Provided is a one-step amination reaction for producing an aminomethyl substituted heterocycloalkane, notably (tetrahydrofuran-2, 5-diyl) dimethanamine.
|
|
WO/2019/039290A1 |
Provided are: an actinic ray-sensitive or radiation-sensitive resin composition that has excellent resolution, exposure latitude, and pattern shape properties; and a resist film, a pattern-forming method, a method for producing an electr...
|
|
WO/2019/027263A1 |
The present application provides a heterocyclic compound represented by Chemical Formula 1, and an organic light-emitting element including same.
|
|
WO/2019/022002A1 |
A compound represented by formula (I) or a salt thereof. (In formula (I), Q1 represents an (un)substituted C6-10 aryl group; Q2 represents an (un)substituted C1-6 alkyl group, an (un)substituted C6-10 aryl group, or a five- to ten-member...
|
|
WO/2019/013542A1 |
The present specification relates to a heterocyclic compound represented by chemical formula 1 and an organic light emitting element comprising the same.
|
|
WO/2019/008156A1 |
The present invention provides novel compounds of formula (I) that are useful as inhibitors of the PD-1/PD-L1 protein/protein interaction. The compounds may be used in the treatment of cancer, infectious diseases and neurodegenerative di...
|
|
WO/2019/004790A1 |
The present specification relates to a heterocyclic compound represented by Chemical Formula 1, and an organic light emitting element including same.
|
|
WO/2019/001268A1 |
The present invention discloses a PEGylated thioxanthone photoinitiator and a photosensitive resin composition. The PEGylated thioxanthone compound is low in toxicity, environmentally friendly, and leaves little residue after curing as a...
|
|
WO/2019/004612A1 |
The present invention provides a novel heterocyclic compound and an organic light-emitting device using same.
|
|
WO/2019/004791A1 |
The present specification relates to a heterocyclic compound represented by Chemical Formula 1, and an organic light emitting element including same.
|
